Harvard Scientist Testifies That State Dispensary Cannabis Lacks Pharmaceutical Quality

Washington, Monday, 6 July 2026.
At a federal hearing, a Harvard expert testified that state dispensary cannabis lacks the purity and consistency of pharmaceutical-grade medicine, underscoring major regulatory hurdles for the industry.